image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Optimal Payments - New Jersey set to legalise online gambling

December 2013

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • OPAY
  • Price:
  • 300p
With New Jersey set to become the third state (after Delaware and Las Vegas) to allow real money online gambling on November 26, Optimal received a welcome boost with the news that it has been declared suitable to offer payment and risk management solutions to New Jersey's internet gambling providers. Numis has put out a new note, upgrading its price target to 350p (whilst rival Canaccord sets a 380p target). In particular, Numis highlights that Optimal has up to US$70m to spend on acquisitions “to diversify the geographical and merchant mix of revenue†with management drawing up a short-list of targets in Europe and the US. Numis also thinks it could be taken over or merged with rival Skrill, generating US$40m cost synergies, ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X